Brief

"On January 17, 2025, the European Medicines Agency (EMA) issued an update regarding Two new vaccines against bluetongue recommended for approval. The EMA has recommended the approval of Bluevac-3 and Syvazul BTV 3 to protect sheep against bluetongue disease, with Bluevac-3 also approved for use in cattle. These vaccines are shown to protect against the newly emerged serotype-3 bluetongue virus (BTV3) responsible for recent outbreaks in Europe."

This content is restricted.

Highlights content goes here...

This content is restricted.

European Medicines Agency (EMA)

Quick Insight
RADA.AI
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Enter your registered username/email id.

Enter your Email

Enter your email id below to signup.
Individual Plan
$125 / month OR $1250 / year
Features
Best for: Researchers, Legal professionals, Academics
Enterprise Plan
Contact for Pricing
Features
Best for: Law Firms, Corporations, Government Bodies